(secondQuint)Clinical Trial Evaluating the Efficacy and Safety of Technosphere Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler.

 Phase 3 clinical trial is designed to examine the efficacy and safety of inhaled prandial TI Inhalation Powder in combination with basal insulin verses insulin aspart in combination with basal insulin in subjects with type 2 diabetes who are suboptimally controlled with their current insulin regimens.

This trial will employ a variety of methods to intensively manage these subjects.

.

 Clinical Trial Evaluating the Efficacy and Safety of Technosphere Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler@highlight

This is an open-label, randomized, forced-titration clinical trial evaluating the efficacy and safety of Technosphere Insulin (TI) Inhalation Powder in combination with insulin glargine versus insulin aspart in combination with insulin glargine in subjects with type 2 diabetes.

